Conversation with The Cancer LetterFree Roche CEO O’Day: Our investment in Flatiron will accelerate their mission March 02, 2018Vol.44 No.09By Matthew Bin Han Ong
Free Roche to acquire Flatiron Health for $2.1 billion,with focus on real-world data March 02, 2018Vol.44 No.09By Matthew Bin Han Ong
Drugs & TargetsFree FDA expands approval of Imfinzi to reduce the risk of NSCLC progressing February 23, 2018Vol.44 No.08
FreeTrials & Tribulations Diversity within Diversity: Lessons from the Latinos of South Texas February 23, 2018Vol.44 No.08By Amelie G. Ramirez and Ruben A. Mesa
FreeIn Brief Frederick Schnell named to new post of COA medical director February 23, 2018Vol.44 No.08
FreeIn Brief Richard Barakat to lead Northwell Health cancer services, research February 23, 2018Vol.44 No.08
FreeIn Brief Denis Guttridge named director of MUSC Darby Children’s Research Institute, associate director at Hollings February 23, 2018Vol.44 No.08
Conversation with The Cancer LetterFree UT Health San Antonio’s link with MD Anderson goes live; How does it work? February 23, 2018Vol.44 No.08By Paul Goldberg
